Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: Male

Summary

LTBI Treatment is effective in prison

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Isoniazid; Rifampin

Criteria

Inclusion Criteria:

• all people who is LTBI, and have ability to sign the informed concent

Exclusion Criteria:

• previously adverse effect from anti-TB medication complete treatment of TB in the pass; active TB AST, ALT > 3 times of normal limit platelet < 150 k/mm3 T-bil > 2 times of normal limit